First, it is the first study to comprehensively explain the relationship between biomarkers and AD from the perspective of mitophagy compared with classic genetic biomarkers such as APP and PSEN1. Second, by combining three datasets, the sample number was sufficient, and the interbatch differences in the datasets were eliminated, avoiding data bias (see Figure 2). The gene discussed is APP; the disease is Alzheimer disease.